News
January 9, 2008 - Avista Capital Partners, a leading private equity firm, has completed its acquisition of Bristol-Myers ...
January 08, 2008
News
January 8, 2008 - Compared with paclitaxel-eluting stents (PES), sirolimus-eluting stents (SES) appear to decrease the risk of in-stent late luminal loss in diabetics with coronary artery disease, new research shows.
January 07, 2008News
January 8, 2008 – The cardiac imaging community has until Jan. 12 to contribute to the Centers for Medicare and Medicaid ...
January 07, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
January 8, 2008 - GE Healthcare has initiated a vendor-independent educational program, designed specifically for ...
January 07, 2008News
January 8, 2008 – Young, obese women with polycystic ovary syndrome (PCOS) may be at increased risk for early subclinical coronary atherosclerosis, independent of the presence of traditional cardiovascular risk factors and novel inflammatory risk markers, according to a study by researchers at the University of Iowa published in the December issue of the Journal of Clinical Endocrinology and Met
January 07, 2008News
January 7, 2008 - Ischemia experienced in brief episodes could protect the heart by preparing it for a heart attack, according to early findings from an animal study by researchers at the University of Cincinnati, which was published in the January issue of the American Journal of Physiology: Heart and Circulatory Physiology.
January 07, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
January 8, 2007 - Cardiac Science Corp. expects 2007 fourth quarter revenue to total approximately $50 million, representing growth of approximately 28 percent compared with the fourth quarter of 2006, thanks to strong growth in revenue from its defibrillation products and cardiac monitoring line.
January 07, 2008News
January 7, 2008 - Osiris Therapeutics Inc. has reclaimed sole worldwide rights to cardiovascular indications for Prochymal and terminated its development and commercialization agreement with Boston Scientific Corp. in order to provide Osiris with the flexibility to enter more strategically beneficial relationships.
January 06, 2008News
January 7, 2008 – Patients with atrial flutter and atrial fibrillation may require additional sites of ablation to ...
January 06, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
January 7, 2008 - Abiomed Inc. has rolled out a new Portable Circulatory Support Driver for both in-hospital and out-of ...
January 06, 2008News
January 7, 2008 - An on-line vascular health activity book that teaches children ages 5-12 how their vascular system ...
January 06, 2008News
January 7, 2008 - Cardica Inc. received nearly $2 million in payments from Cook Medical (Cook) for reaching milestones pursuant to its development agreements with Cook, including a vascular closure device collaboration agreement and initial development milestone for a device to repair heart defects.
January 06, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
January 7, 2008 - Imaging for early cardiovascular disease that causes heart attack and stroke is the focus of the High ...
January 06, 2008News
January 7, 2008 - Boston Scientific Corp. has completed the sale of its Cardiac Surgery and Vascular Surgery businesses ...
January 06, 2008News
January 3, 2008 - A study reported in the Jan. 3 New England Journal of Medicine found that one third of patients who ...
January 03, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now